Winship Preceptorship for Breast/Lung Oncologists from Latin America

The Winship Preceptorship for Breast/Lung Oncologists from Latin America program seeks to provide educational exposure for early- to mid-career practicing oncologists from Brazil, Argentina, Mexico and Colombia.

Hosted at Winship Cancer Institute's main campus location in Atlanta, observers will learn the optimal management of patients with advanced stages of lung cancer and breast cancer.

Winship thoracic and breast medical oncology experts will serve as preceptors to the observers as they evaluate and take care of cancer patients in various clinical settings. Through these and other interactions, the visiting observers will be able to adapt lessons learned to improve their local practice back home.

Program Description

The preceptorship is specifically designed for early- to mid-career oncologists from the Latin American countries of Brazil, Argentina, Mexico and Colombia. Observers are expected to be in independent oncology practice and within six years of final oncology training with an established position to return to immediately following program participation. Both academic and general community oncology practitioners are eligible for this program.

Winship breast oncologist Dr. Keerthi Gogineni is one of the physicians whom observers will shadow as she performs patient evaluations and care.

The preceptorship is a deep immersion program over a two week period. Applicants will be selected to participate in the session scheduled for October 10-23 (arrival on October 9; departure on October 24). Additional sessions are being planned for 2021.

Observers will:

  • function in an observational role while shadowing physicians as they perform patient evaluations and direct treatment;
  • directly observe all aspects of medical oncology care for patients with lung and breast cancer without having any direct clinical responsibilities;
  • attend specialized tumor boards for lung cancer and breast cancer where complex cases are discussed;
  • attend various presentations at research meetings and educational seminars including weekly research working group meetings.

The program involves a mixture of didactic lectures along with hands-on observership in a variety of clinical settings. The didactic component will consist of two days of lectures focusing on genomic-driven management of breast cancer and lung cancer. This would run before and in between two weeks of clinical rotations including one week in the lung cancer clinic and one week in the breast medical oncology clinic.

Observers will arrive the day prior to the start of the program. Here's a sample schedule:

  • Day one: Pre-exposure program survey and didactics (breast/lung)
  • Day two through six: Clinical exposures
  • Day seven: Didactics (breast/lung)
  • Day eight through twelve: Clinical exposures and program participant interviews
  • Final day: Post-exposure program survey and departures

Key Objectives

This preceptorship program is designed as a formal continuing education program that will lead to behavior and performance changes in the observers and ultimately result in system changes at home that improve overall health of the society. By participating in this program, observers are expected to:

  • become familiar with the latest systemic treatment modalities (targeted therapies, immunotherapy and experimental cell therapy approaches) currently employed in the standard treatment of patients with advanced cancer, in particular, lung and breast cancer;
  • gain exposure to advanced pathological diagnosis of cancer, including immunohistochemistry and molecular diagnostics;
  • gain appreciation for a team-based approach to optimal cancer care through attendance in multidisciplinary clinics and tumor boards;
  • become familiar with clinical research as a key tool to advance cancer care by attending research team meetings, Winship grand rounds, invited lectures and working group meetings.

Accommodations and Travel

Accommodation expenses and round-trip travel to the United States including visa application fees will be covered by the program. Health insurance and a stipend to cover a reasonable cost of living including meals will be provided to trainees for the duration of the program. All observers will be housed at the Emory Conference Center Hotel during the June and October sessions. No charges will be imposed for participating in the program.

Application Process

Steps to apply:

  1. Complete the application form (button link below) and submit via email to Barbara Powley, program coordinator, at bpowley@emory.edu.
  2. Complete needs assessment survey (button link below).

Applications are accepted on a rolling basis for the June and October sessions.

The sessions originally scheduled for April and June of 2020 have been cancelled due to the current situation with the coronavirus (COVID-19). All received applications for the April and June sessions will be deferred to October.

Credentialing Process

All observers need to also apply for credentialing providing proof of immunizations, appropriate visa documents and other requested documentation before obtaining final approval. Please complete this alongside Preceptorship application and email the completed copy to observership.credentialing@emoryhealthcare.org.

Photo of  Taofeek Owonikoko, MD, PhD, MSCR
Taofeek Owonikoko, MD, PhD, MSCR

Taofeek Owonikoko, MD, PhD, MSCR

Co-Leader, Discovery & Developmental Therapeutics Program
Winship Cancer Institute of Emory University

Dr. Owonikoko's clinical specialties include lung cancer, thyroid cancer and other cancers of the aerodigestive tract.

Photo of  Keerthi Gogineni, MD, MSHP
Keerthi Gogineni, MD, MSHP

Keerthi Gogineni, MD, MSHP

Assistant Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine

Dr. Gogineni is committed to caring for patients with breast cancer and conducting research that evaluates and improves access to oncology care for disenfranchised patients.

Photo of  Rebecca Pentz, PhD
Rebecca Pentz, PhD

Rebecca Pentz, PhD

Professor of Hematology and Oncology in Research Ethics
Emory University School of Medicine

Dr. Pentz works directly with innovative oncology researchers to develop and design cutting edge ethical research.

Cascade Link  TOP